Clinical and economic burden of pneumococcal disease in US adults aged 19–64 years with chronic or immunocompromising diseases: an observational database study

BACKGROUND: Despite the widespread availability of pneumococcal vaccines, rates of pneumococcal disease are disproportionately high in adults with chronic and immunocompromising conditions. This study investigated pneumococcal disease rates and associated resource utilization and costs in this group...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dongmu, Petigara, Tanaz, Yang, Xiaoqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116536/
https://www.ncbi.nlm.nih.gov/pubmed/30157781
http://dx.doi.org/10.1186/s12879-018-3326-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116536/
https://www.ncbi.nlm.nih.gov/pubmed/30157781
http://dx.doi.org/10.1186/s12879-018-3326-z

Ejemplares similares